New Research for Migraines and Medical Cannabis - November 2017 Release

TrueMedicines, the pioneer in data science for medical cannabis, completes an initial market research study on the effects of medical cannabis on migraines. Findings, including top reviewed strains and side effects ratings, are published at www.TrueMedicines.com

TrueMedicines is committed to bringing research to consumers for them to make informed decisions around plant-based nutraceuticals, including medical cannabis. We collect market research data from hundreds of thousands of real customer reviews and applied complex data science algorithms to help identify patterns in the data. 

Disclaimer: TrueMedicines research is informational and not personal medical advice. Our market research is not medical advice and is not intended diagnose, prevent, treat or cure any diseases. Contact your qualified physician for medical advice.


Leave a comment

Please note, comments must be approved before they are published